Activation of peroxisome proliferator-activated receptor-α decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Irukayama Tomobe, Yoko ^a   Miyauchi, Takashi ^a   Kasuya, Yoshitoshi ^a   Sakai, Satoshi ^a   Goto, Katsutoshi ^b   Yamaguchi, Iwao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cardiomyocytes; Endothelin 1; p38 MAPK; PPAR

Indexed keywords

ENDOTHELIN 1; FENOFIBRATE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE C; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELL SIZE; CELLS, CULTURED; ENDOTHELIN-1; HYPERTROPHY; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR ALPHA; PROCETOFEN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 11144250318     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166303.33313.01     Document Type: Conference Paper

References (21)

1. Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Anuu Rev Physiol. 1999;61:391-415.
2. Suzuki T, Hoshi H, Mitsui Y, et al. Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS Lett. 1990;268:149-151.
3. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alteration in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993;73:887-897.
4. Yorikane R, Sakai S, Miyauchi T, et al. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 1993;332:31-34.
5. Sakai S, Miyauchi T, Kobayashi M, et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996a;384:353-355.
6. Sakai S, Miyauchi T, Yamaguchi I. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium rats with heart failure. Circulation. 2000;101:2849-2853.
7. Sugden PH. Signaling in myocardial hypertrophy; life after calcineurin? Circ Res. 1999;84:633-646.
8. Kliewer SA, Forman BM, Lumberg B, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U.S.A. 1994;91:7355-7359.
9. Forman BM, Chen J, Evans RM. Hyperlipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U.S.A. 1997;94:4312-4317.
10. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645-650.
11. Tugwood JD, Issemann I, Anderson RG, et al. The mouse peroxisome proliferator-acivated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 1992;11:433-439.
12. Yamamoto K, Ohki R, Lee RT, Ikeda U, et al. Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation. 2001;104:1670-1675.
13. 2-terminal kinase pathway. Circulation. 2004;109:904-910.
14. Zechner D, Thuerauf DJ, Hanford DS, et al. A role for the p38 mitogen-acivated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol. 1997;139:115-127.
15. Kakinuma Y, Miyauchi T, Kobayashi T, et al. Myocardial expression of endothelin-2 is altered reciprocally to that of endothelin-1 during ischemia of cardiomyocytes in vitro and during heart failure in vivo. Life Sci. 1999;65:1671-1683.
16. Sugden PH. Signaling in myocardial hypertrophy; life after calcineurin? Circ Res. 1999;84:633-646.
17. Thorburn A, Thorburn J, Chen S-Y, et al. Hras-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem. 1993;268:2244-2249.
18. Zou Y, Komuro I, Yamazaki T, et al. Protein kinase C, but not tyrosine kinases or ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem. 1996;271:33592-33597.
19. Choukroun G, Hajjar R, Kyriakis JM, et al. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J Clin Invest. 1998;102:1311-1320.
20. Caelles C, Gonzalez-Sancho JM, Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Gene Dev. 1997;11:3351-3364.
21. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483-16486.